ArticleMedicina (Kaunas, Lithuania)2025
Assessing the Influence of Proton Pump Inhibitors on Clinical Outcomes in Hormone Receptor-Positive Metastatic Breast Cancer Patients Receiving CDK4/6 Inhibitors: Evidence from a Ribociclib-Dominant Cohort.
Enes Erul et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.